| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2000-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_283c205fb692df03afe97f3ef6922fd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d45a27b3f88e15948db79de145ccbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd6b607a7cb34af0396ddc7a92cb806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4094664b06c4d06aaaa9f146ba439bbd |
| publicationDate |
2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002087962-A |
| titleOfInvention |
Water-soluble and stable composition |
| abstract |
(57) [Problem] To develop a water-soluble and stable composition of conivaptan hydrochloride [Solution] Powder X obtained by using Cu-Kα ray An easily water-soluble and stable pharmaceutical composition comprising a crystal of conivaptan hydrochloride as an active ingredient, having a strongest peak near a lattice spacing of 7.82 in a line diffraction spectrum. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105884778-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103497195-A |
| priorityDate |
2000-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |